Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mauser

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort studyI Plug, J G Van Der Bom, M Peters, et al.
Thrombosis and Haemostasis|January 12, 2001
Endogenous clotting factor activity and long-term outcome in patients with moderate haemophiliaK Fischer, J G van der Bom, E P Mauser-Bunschoten, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Evaluation of wet pasteurization of a factor VIII concentrate produced by controlled-pore silica adsorptionH Hiemstra, C E Nieuweboer, M A Idoe, et al.
Blood|April 15, 1993
A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study GroupF R Rosendaal, H K Nieuwenhuis, H M van den Berg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcomeK Fischer, J G van der Bom, P Molho, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2011
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual useE Berntorp, D Keeling, M Makris, et al.
Thrombosis and Haemostasis|January 22, 2016
Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding ratesAnnelies Nijdam, Wouter Foppen, Piet De Kleijn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 11, 2012
Guidelines for the management of hemophiliaA Srivastava, A K Brewer, E P Mauser-Bunschoten, et al.
Haematologica|April 12, 2005
Factor VIII half-life and clinical phenotype of severe hemophilia AKarin van Dijk, Johanna G van der Bom, Peter J Lenting, et al.
Vox Sanguinis|January 1, 1992
Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virusD Bresters, H T Cuypers, H W Reesink, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort studyI Plug, J G Van Der Bom, M Peters, et al.
Thrombosis and Haemostasis|January 12, 2001
Endogenous clotting factor activity and long-term outcome in patients with moderate haemophiliaK Fischer, J G van der Bom, E P Mauser-Bunschoten, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1990
Evaluation of wet pasteurization of a factor VIII concentrate produced by controlled-pore silica adsorptionH Hiemstra, C E Nieuweboer, M A Idoe, et al.
Blood|April 15, 1993
A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study GroupF R Rosendaal, H K Nieuwenhuis, H M van den Berg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcomeK Fischer, J G van der Bom, P Molho, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 3, 2011
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual useE Berntorp, D Keeling, M Makris, et al.
Thrombosis and Haemostasis|January 22, 2016
Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding ratesAnnelies Nijdam, Wouter Foppen, Piet De Kleijn, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 11, 2012
Guidelines for the management of hemophiliaA Srivastava, A K Brewer, E P Mauser-Bunschoten, et al.
Haematologica|April 12, 2005
Factor VIII half-life and clinical phenotype of severe hemophilia AKarin van Dijk, Johanna G van der Bom, Peter J Lenting, et al.
Vox Sanguinis|January 1, 1992
Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virusD Bresters, H T Cuypers, H W Reesink, et al.
Pageof 17